Stock Updates

Today’s Top Gainers in the Market BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from Healthcare

Today’s top gainers include the company BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which is in the industry Biotechnology, gaining 0.57% today. In the last week its performance is -0.51%, and 6.94% for the past quarter. Currently, BioMarin Pharmaceutical Inc., BMRN has a target price of 119.29, so today’s gain of 0.57% is a significant step towards its target price. The GAP today is therefore 0.12%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), has a market cap of 16256.87, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 99.30%.

At the current price of 95.73, it has a dividend yield of *TBA, and its target price is 119.29. This is with a profit margin of -54.50%, and total debt/equity of 0.35. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a P/E of *TBA, as well as a forward P/E of *TBA.

With a current EPS of -3.27, and a forecasted EPS growth for next year at 73.00%,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has had a EPS growth for the past five years at -21.30%. For the next five years EPS growth is projected to be 25.00%.

Performance for the year is -25.94%. Since its IPO date on 7/26/1999, the total performance to date is -8.62%.

Volume today for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), is 801783, while its average volume is 1880.17. Whilst the total gain today was 0.57%, it did have a day high of -6.60%.

Volatility for this week has been at 2.55%, and 2.94% for the month. The 52-week low for BioMarin Pharmaceutical Inc., BMRN has been 54.10%, while the 52-week-high has reached -28.94%.

Looking at its return of investments, which is -4.20%, and its return on assets is -15.10%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has an operating margin of -65.20%. With a sales growth of 20.00% quarter over quarter. Bearing in mind that BioMarin Pharmaceutical Inc., BMRN is in the sector Healthcare, its long-term debt/equity is 0.34, and has a current ratio of 3 and 2.1 for quick ratio.

So what is the value of BioMarin Pharmaceutical Inc.? Well its PEG is *TBA, and the P/S is 16.7, along with a P/B of 8.12. Meanwhile it has a p/cash of 32.3.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment